As of Apr 20
| +0.51 / +0.72%|
The 5 analysts offering 12-month price forecasts for Magellan Health Inc have a median target of 69.00, with a high estimate of 85.00 and a low estimate of 62.00. The median estimate represents a -2.72% decrease from the last price of 70.93.
The current consensus among 6 polled investment analysts is to Hold stock in Magellan Health Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.